Brachytherapy
Volume 5, Issue 3 , Pages 165-173 , July 2006

Prostate brachytherapy postimplant dosimetry: A comparison of suture-embedded and loose seed implants

Received 15 February 2006 ,Revised 16 May 2006 ,Accepted 19 May 2006.

References 

  1. Grimm PD, Blasko JC, Sylvester JE, et al. 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:31–40
  2. Chauveinc L, Osseili A, Flam T, et al. Iodine 125 seed migration after prostate brachytherapy: A study of 170 patients. Cancer Radiother. 2004;8:211–216
  3. Ankem MK, DeCarvalho VS, Harangozo AM, et al. Implications of radioactive seed migration to the lungs after prostate brachytherapy. Urology. 2002;59:555–559
  4. Older RA, Synder B, Krupski TL, et al. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. J Urol. 2001;165:1590–1592
  5. Nag S, Vivekanandam S, Martinez-Monge R. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1997;39:667–670
  6. Susman E. Wandering brachytherapy seeds need to be monitored. Lancet Oncol. 2001;2:466
  7. Eshleman JS, Davis BJ, Pisansky TM, et al. Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: Extraprostatic seed placement correlates with migration. Int J Radiat Oncol Biol Phys. 2004;59:419–425
  8. Tapen EM, Blasko JC, Grimm PD, et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;42:1063–1067
  9. Merrick GS, Butler WM, Dorsey AT, et al. Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:215–220
  10. Fuller DB, Koziol JA, Feng AC. Prostate brachytherapy seed migration and dosimetry: Analysis of stranded sources and other potential predictive factors. Brachytherapy. 2004;3:10–19
  11. Al-Qaisieh B, Carey B, Ash D, et al. The use of linked seeds eliminates lung embolization following permanent seed implantation for prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59:397–399
  12. Lee WR, deGuzman AF, Tomlinson SK, et al. Radioactive sources embedded in suture are associated with improved postimplant dosimetry in men treated with prostate brachytherapy. Radiother Oncol. 2002;65:123–127
  13. Fagundes HM, Keys RJ, Wojcik MF, et al. Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPID Strand: A dosimetric analysis. Brachytherapy. 2004;3:136–140
  14. Sidhu S, Morris WJ, Spadinger I, et al. Prostate brachytherapy post-implant dosimetry: A comparison of prostate quadrants. Int J Radiat Oncol Biol Phys. 2002;52:544–552
  15. Hilts M, Spadinger I, Keyes M. A comparison of methods for calculating rectal dose following I-125 prostate brachytherapy implants. Int J Radiat Oncol Biol Phys. 2002;53:775–785
  16. Grimm PD, Blasko JC, Ragde H. Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early-stage prostate cancer: technical concepts in planning, operative technique, and evaluation. In:  Schellhammer PF editors. New techniques in prostate surgery. Philadelphia, PA: WB Saunders; 1994;p. 113–126
  17. Lee EK, Zaider M. On the determination of an effective planning volume for permanent prostate implants. Int J Radiat Oncol Biol Phys. 2001;49:1197–1206
  18. Van Gellekom MP, Moerland MA, Wijrdeman HK, et al. Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID Strands. Radiother Oncol. 2004;3:49–56
  19. Saw CB, Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys. 1991;20:135–139
  20. Waterman FM, Dicker AP. Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan. Med Phys. 2000;27:448–451
  21. Bucci J, Spadinger I, Hilts M, et al. Urethral and periurethral dosimetry in prostate brachytherapy: Is there a convenient surrogate?. Int J Radiat Oncol Biol Phys. 2000;54:1235–1242
  22. Crook J. Commentary on “A comparison of the precision of seeds deposited as loose seeds vs. suture-embedded seeds: A randomized trial” and “Prostate brachytherapy seed migration and dosimetry: Analysis of stranded sources and other potential predictive factors”: To strand or not to strand—Is this really the question?. Brachytherapy. 2004;3:20–21
  23. Kaplan ID, Meskell PM, Lieberfarb M, et al. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: A randomized trial. Brachytherapy. 2004;3:7–9
  24. McLaughlin P, Narayana V, Pan C, et al. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds. Int J Radiat Oncol Biol Phys. 2006;64:144–150
  25. Crook J, Pearson S, Williams T. The pros and cons of linked vs loose seeds. CARO Annual Meeting. Montreal, Canada, October 3-5, 2003. Radiother Oncol 2003;69(Suppl. 1):157.
  26. Bucci J, Morris WJ, Keyes M, et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;53:91–98

 Financial disclosure: This work was supported, in part, by an unrestricted educational grant from Oncura Inc.

PII: S1538-4721(06)00202-9

doi: 10.1016/j.brachy.2006.05.003

Brachytherapy
Volume 5, Issue 3 , Pages 165-173 , July 2006

Article Tools

* Image Usage & Resolution